A method of treating otosclerosis in a human in need thereof by administering a bisphosphonate in a defined dosing schedule. The invention demonstrates an effective response and sustained benefit in the treatment of otosclerosis. Particularly, the method involves administration of a bisphosphonate in a stepped-up dosage amount, e.g., in a dose that is at least one and a half times the recommended dose for osteoporosis. It also includes administration of a time-dependent dose of more than one bisphosphonate, specifically, alternating administration of a first bisphosphonate with a second bisphosphonate. The inventive method further includes intravenous administration of a bisphosphonate, and optionally oral administration of a bisphosphonate. The present invention further contemplates a kit for facilitating the alternating bisphosphonate dosing schedule

 
Web www.patentalert.com

< SOLUTION HAVING BIOCIDAL ACTIVITY

> Nanoveson.TM.: treatment, biomarkers and diagnostic tests for liver diseases and comorbid diseases

> Compositions from Garcinia as Aromatase Inhibitors for Breast Cancer Chemoprevention and Chemotherapy

~ 00533